These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 25887118
1. IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment. Zickert A, Amoudruz P, Sundström Y, Rönnelid J, Malmström V, Gunnarsson I. BMC Immunol; 2015 Feb 12; 16(1):7. PubMed ID: 25887118 [Abstract] [Full Text] [Related]
2. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Chen DY, Chen YM, Wen MC, Hsieh TY, Hung WT, Lan JL. Lupus; 2012 Nov 12; 21(13):1385-96. PubMed ID: 22892208 [Abstract] [Full Text] [Related]
3. Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis. Zickert A, Palmblad K, Sundelin B, Chavan S, Tracey KJ, Bruchfeld A, Gunnarsson I. Arthritis Res Ther; 2012 Feb 20; 14(1):R36. PubMed ID: 22348591 [Abstract] [Full Text] [Related]
4. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis. AlFadhli S, AlFailakawi A, Ghanem AA. Int J Rheum Dis; 2016 May 20; 19(5):512-20. PubMed ID: 25496163 [Abstract] [Full Text] [Related]
15. Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis. Yap DY, Yung S, Zhang Q, Tang C, Chan TM. Lupus; 2016 Jan 20; 25(1):46-53. PubMed ID: 26251400 [Abstract] [Full Text] [Related]
16. Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomes. Hanaoka H, Kuwana M, Takeuchi T. Int J Rheum Dis; 2015 Sep 20; 18(7):768-75. PubMed ID: 26179413 [Abstract] [Full Text] [Related]
17. Effect of induction therapy on circulating T-helper 17 and T-regulatory cells in active proliferative lupus nephritis. Shenoy S, Chaurasia S, Edavalath S, Zanwar A, Agrawal V, Aggarwal A, Misra R. Int J Rheum Dis; 2018 May 20; 21(5):1040-1048. PubMed ID: 29392921 [Abstract] [Full Text] [Related]
18. Interferon (IFN)-λ is a potential mediator in lupus nephritis. Zickert A, Oke V, Parodis I, Svenungsson E, Sundström Y, Gunnarsson I. Lupus Sci Med; 2016 May 20; 3(1):e000170. PubMed ID: 27933198 [Abstract] [Full Text] [Related]
19. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis. Parodis I, Ding H, Zickert A, Arnaud L, Larsson A, Svenungsson E, Mohan C, Gunnarsson I. Scand J Rheumatol; 2017 Jul 20; 46(4):263-272. PubMed ID: 27973968 [Abstract] [Full Text] [Related]